Used as a starting material in the synthesis of central nervous system (CNS)-related pharmaceuticals, particularly those acting on serotonin receptors. It is employed in the development of drugs for treating depression, anxiety, or mood disorders. Derivatives from this structure have potential in modulating brain function, and some are under study as novel anti-migraine agents acting via specific mechanisms on 5-HT1D/1B receptors. As a chiral building block, it supports asymmetric synthesis to introduce stereochemistry in complex molecules and is valuable in pharmaceutical research and development.